Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jan 17;294(6565):141–142. doi: 10.1136/bmj.294.6565.141

Cannabis: dangers and possible uses.

C H Ashton
PMCID: PMC1245158  PMID: 3109541

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman D. N., Rawlins M. D. Therapeutic potential of cannabinoids. Br Med J (Clin Res Ed) 1982 Apr 24;284(6324):1211–1212. doi: 10.1136/bmj.284.6324.1211-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Campbell A. M., Evans M., Thomson J. L., Williams M. J. Cerebral atrophy in young cannabis smokers. Lancet. 1971 Dec 4;2(7736):1219–1224. doi: 10.1016/s0140-6736(71)90542-3. [DOI] [PubMed] [Google Scholar]
  3. Carney M. W., Bacelle L., Robinson B. Psychosis after cannabis abuse. Br Med J (Clin Res Ed) 1984 Apr 7;288(6423):1047–1047. doi: 10.1136/bmj.288.6423.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chesher G. B., Jackson D. M. The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol. Pharmacol Biochem Behav. 1985 Jul;23(1):13–15. doi: 10.1016/0091-3057(85)90122-4. [DOI] [PubMed] [Google Scholar]
  5. Co B. T., Goodwin D. W., Gado M., Mikhael M., Hill S. Y. Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomography. JAMA. 1977 Mar 21;237(12):1229–1230. [PubMed] [Google Scholar]
  6. Cronin C. M., Sallan S. E., Gelber R., Lucas V. S., Laszlo J. Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):43S–50S. doi: 10.1002/j.1552-4604.1981.tb02572.x. [DOI] [PubMed] [Google Scholar]
  7. Fink M. Effects of acute and chronic inhalation of hashish, marijuana, and delta 9-tetrahydrocannabinol on brain electrical activity in man: evidence for tissue tolerance. Ann N Y Acad Sci. 1976;282:387–398. doi: 10.1111/j.1749-6632.1976.tb49911.x. [DOI] [PubMed] [Google Scholar]
  8. Gersten S. P. Long-term adverse effects of brief marijuana usage. J Clin Psychiatry. 1980 Feb;41(2):60–61. [PubMed] [Google Scholar]
  9. Gross H., Ebert M. H., Faden V. B., Goldberg S. C., Kaye W. H., Caine E. D., Hawks R., Zinberg N. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol. 1983 Jun;3(3):165–171. [PubMed] [Google Scholar]
  10. Hannerz J., Hindmarsh T. Neurological and neuroradiological examination of chronic cannabis smokers. Ann Neurol. 1983 Feb;13(2):207–210. doi: 10.1002/ana.410130219. [DOI] [PubMed] [Google Scholar]
  11. Karacan I., Fernández-Salas A., Coggins W. J., Carter W. E., Williams R. L., Thornby J. I., Salis P. J., Okawa M., Villaume J. P. Sleep electroencephalographic-electrooculographic characteristics of chronic marijuana users: part I. Ann N Y Acad Sci. 1976;282:348–374. doi: 10.1111/j.1749-6632.1976.tb49909.x. [DOI] [PubMed] [Google Scholar]
  12. Knudsen P., Vilmar T. Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand. 1984 Feb;69(2):162–174. doi: 10.1111/j.1600-0447.1984.tb02482.x. [DOI] [PubMed] [Google Scholar]
  13. Koukkou M., Lehmann D. Correlations between cannabis-induced psychopathology and EEG before and after drug ingestion. Pharmakopsychiatr Neuropsychopharmakol. 1978 Sep;11(5):220–227. doi: 10.1055/s-0028-1094581. [DOI] [PubMed] [Google Scholar]
  14. Kuehnle J., Mendelson J. H., Davis K. R., New P. F. Computed tomographic examination of heavy marijuana smokers. JAMA. 1977 Mar 21;237(12):1231–1232. [PubMed] [Google Scholar]
  15. MacInnes D. C., Miller K. M. Fatal coronary artery thrombosis associated with cannabis smoking. J R Coll Gen Pract. 1984 Oct;34(267):575–576. [PMC free article] [PubMed] [Google Scholar]
  16. Maykut M. O. Health consequences of acute and chronic marihuana use. Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(3):209–238. doi: 10.1016/0278-5846(85)90085-5. [DOI] [PubMed] [Google Scholar]
  17. McIsaac W., Fritchie G. E., Idänpän-Heikkilä J. E., Ho B. T., Englert L. F. Distribution of marihuana in monkey brain and concomitant behavioural effects. Nature. 1971 Apr 30;230(5296):593–594. doi: 10.1038/230593a0. [DOI] [PubMed] [Google Scholar]
  18. Murray J. B. Marijuana's effects on human cognitive functions, psychomotor functions, and personality. J Gen Psychol. 1986 Jan;113(1):23–55. doi: 10.1080/00221309.1986.9710540. [DOI] [PubMed] [Google Scholar]
  19. Noyes R., Jr, Brunk S. F., Avery D. A., Canter A. C. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther. 1975 Jul;18(1):84–89. doi: 10.1002/cpt197518184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Orr L. E., McKernan J. F. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. J Clin Pharmacol. 1981 Aug-Sep;21(8-9):76S–80S. doi: 10.1002/j.1552-4604.1981.tb02578.x. [DOI] [PubMed] [Google Scholar]
  21. Razdan R. K., Howes J. F., Pars H. G. Development of orally active cannabinoids for the treatment of glaucoma. NIDA Res Monogr. 1983 Apr;43:157–163. [PubMed] [Google Scholar]
  22. Szymanski H. V. Prolonged depersonalization after marijuana use. Am J Psychiatry. 1981 Feb;138(2):231–233. doi: 10.1176/ajp.138.2.231. [DOI] [PubMed] [Google Scholar]
  23. Tunving K. Psychiatric effects of cannabis use. Acta Psychiatr Scand. 1985 Sep;72(3):209–217. doi: 10.1111/j.1600-0447.1985.tb02597.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES